CNE100006FN4
CNE100006FN4
SICHUAN BIOKIN PHARMACEUTICAL C
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q2 '26 30.06.2026 | Q1 '26 31.03.2026 |
|---|---|---|---|
Market & Enterprise Value | |||
Market Cap | 94.68B EUR | 121.4B EUR | 114.78B EUR |
Enterprise Value | 90.96B EUR | 123.21B EUR | 116.13B EUR |
Valuation Multiples | |||
Trailing P/E | -- | -- | -- |
Forward P/E | -- | -- | -- |
Price to Sales | 37.33x | 162.88x | 159.41x |
Price to Book | 20.54x | 26.33x | 20.34x |
EV/Revenue | 35.86x | 165.31x | 161.29x |
EV/EBITDA | -79.57x | -- | -- |
Price to FCF (P/FCF) | -- | -- | -- |
EV/FCF | -- | -- | -- |
FCF Yield | -1.38% | -1.22% | -0.93% |